期刊文献+

质子泵抑制剂的处方点评 被引量:2

Prescription review on the proton pump inhibitor
下载PDF
导出
摘要 目的:探讨质子泵抑制剂在临床应用时的处方点评情况。方法:抽取门诊信息管理系统中3720份使用PPIs的病历,通过等距抽样法,采用逢十抽一的方式,对其中372份随机选择,将不完整病历和未归档病历自动剔除。依据点评标准,评估合理使用情况。结果:372份病历中,男176份(47.3%),女196份(52.7%)。0~18岁4份,18~65岁283份,>65岁85份。合理病历212份(56.9%),其余160例(43.0%)不合理病历。不合理病历分类包括药物相互作用、给药途径、重复用药、无使用指征、超常用药、疗程偏长。结论:门诊在PPIs应用上,总体存在不甚合理的情况,药品相互作用、用量、使用指征等各方面均有一些问题存在,需加强对药品的了解,不断更新知识,依据患者实际情况给药,以促进药物合理应用。 Objective:To explore the prescription review situation of proton pump inhibitor in the clinical application.Methods:3720 copies of medical records using PPIs were selected in the outpatient information management system.Through the isometricsampling method,using every ten taking one method,372 copies were randomly selected,and the incomplete medical records andnot archived medical records were automatically removed.According to the standard of review,the reasonable use situation wasassessed.Results:In 372 copies of medical records,176 copies(47.3% ) were men,and 196 copies(52.7% ) were women;4 copieswere 0 to 18 years old,283 copies were 18 to 65 years old,and 85 copies were more than 65 years old.The other 160 copies(43%)were irrational medical records.The irrational medical records classification includes drug interactions,route of administration,repeated use,no use indications,excessive use,too long treatment.Conclusion:The application of PPIs in clinic overall exist not veryreasonable,the drug interactions,dosage,use refers and other have some problems.It needs to strengthen the understanding of thedrug,and constantly update knowledge,administration according to the actual situation of patients to promote the drug reasonableapplication.
作者 罗凤花 Luo Fenghua(Dahua County People's Hospital of Hechi City,Guangxi 530800)
出处 《中国社区医师》 2016年第34期14-14,16,共2页 Chinese Community Doctors
关键词 质子泵抑制剂 处方点评 不合理应用 Proton pump inhibitor Prescription review Irrational application
  • 相关文献

参考文献2

二级参考文献13

  • 1陈玫芬,陈辉邦.注射用泮托拉唑钠在4种输液中的配伍稳定性[J].海峡药学,2005,17(5):20-22. 被引量:25
  • 2胡伏莲,韩英,孙忠实,张泰昌.消化系统合理用药专家圆桌会议纪要[J].中国医院用药评价与分析,2006,6(3):129-133. 被引量:12
  • 3于成功,吴寒.质子泵抑制剂的临床应用与研究进展[J].中华消化内镜杂志,2007,24(1):74-75. 被引量:37
  • 4中华人民共和国国家卫生和计划生育委员会.国家卫生计生委等3部门关于加强合理用药健康教育工作的通知[EB/OL].(2013-10-31)[2014-07-05].http://www.nhfpc.gov.cn/xcs/s3581/201310/321ac9f2b1c24302a8b4ebde1280c54e.shtml.
  • 5Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors[J]. BMJ (Clinical Research Ed.), 2008, 336(7634):2-3.
  • 6Saman Chubineh, John Birk. Proton Pump Inhibitors: The Good, the Bad, and the Unwanted[J]. Southern Medical Journal, 2012, 11(105):613- 618.
  • 7Lanza F, Chan F, Quigley E. Guidelines for prevention of NSAID- related ulcer complications[J]. The American Journal f Gastroenterology. 2009, 104(3):728-738.
  • 8高申.质子泵抑制剂临床应用的药学监护[M].人民卫生出版社,2013:26-28.
  • 9Juurlink D, Gomes T, Mamdani M, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J]. CMAJ: Canadian Medical Association Journal = Journal De L'associatian Medicale Canadienne. 2009, 180(7):713-718.
  • 10Clark D, Strandell J. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?[J]. European Journal Of Clinical Pharmacology, 2006, 62(6):473-479.

共引文献175

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部